← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2016-11-21

Drug application

FDA Application #

ANDA206974

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMIVUDINE

Generic name

LAMIVUDINE

Active ingredients

LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SOMERSET THERAPS LLC

Manufacturer

Ingenus Pharmaceuticals, LLC

First approval

2016-11-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown